Belgium· BE-AMP-SAM303861-00
Priorix-Tetra
A masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt product containing mumps virus, registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt is registered in 10 of 19 countries.
Countries holding a registration under ATC J07BD54 (masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt · ATC J07BD54
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Mumps virus
- Manufacturer
- GlaxoSmithKline Biologicals
- Country
- Belgium (BE)
- ATC code
- J07BD54
- ATC class
- Masern, Kombinationen mit Mumps, Röteln und Varicella, lebend abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BD54
Masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt, as other registers publish it.
- FinlandPriorix TetraGlaxoSmithKline Biologicals SA
- FinlandPriorix TetraGlaxoSmithKline Biologicals SA
- IcelandPriorix-TetraGlaxoSmithKline Pharma A/S
- BelgiumPriorix-TetraGlaxoSmithKline Biologicals
- PolandPriorix-TetraGlaxoSmithKline Biologicals S.A.
- PolandPriorix-TetraGlaxoSmithKline Biologicals S.A.
- DenmarkPriorix-TetraGlaxoSmithKline Pharma A/S
- BelgiumPriorix-TetraGlaxoSmithKline Biologicals
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d59a0f2-8349-41e6-a95a-7878a457aa70 GET /v1/drugs/4d59a0f2-8349-41e6-a95a-7878a457aa70?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Priorix-Tetra",
"name_fr": "Priorix-Tetra",
"name_nl": "Priorix-Tetra",
"amp_code": "SAM303861-00",
"strengths": null,
"pack_count": 3,
"substances": [
"Mumps virus",
"Measles Virus",
"Virus Rubella",
"Varicella Virus"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Measles, Combinations with Mumps, Rubella and Varicella, Live Attenuated",
"authorisation_numbers": [
"BE303861"
]
}See everything about masern, kombinationen mit mumps, röteln und varicella, lebend abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.